← Open Payments lookup

NPI 1831274026: Open Payments

NPI 1831274026. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$274 in 17 payments from 4 companies in 2025. Trend: 2023 $324 · 2024 $284 · 2025 $274

Food & beverage: $274
CompanyPaymentsAmount
Alkermes, Inc.11$148
Teva Pharmaceuticals USA, Inc.3$60
Janssen Pharmaceuticals, Inc2$45
Luye Pharma (USA) Ltd.1$21

Products named: ARISTADA, UZEDY, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE.